Journal
FRONTIERS IN IMMUNOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.558143
Keywords
γ δ T cells; IL-17; graft-versus-host disease; graft-versus-leukemia; hematopoietic stem cell transplantation
Categories
Funding
- National Key R&D Program of China [2017YFA0104502, 2016YFC0902800]
- National Natural Science Foundation of China [81571556, 81730003, 81470346]
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- National University of Singapore
Ask authors/readers for more resources
Disease relapse and graft-versus-host disease (GVHD) are the major complications affecting the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT). While the functions of alpha beta T cells are extensively studied, the role of donor gamma delta T cells in allo-HSCT is less well defined. Using TCR delta(-/-) donors lacking gamma delta T cells, we demonstrated that donor gamma delta T cells were critical in mediating graft-versus-leukemia (GVL) effect during allo-HSCT. In the absence of donor gamma delta T cells, IFN-gamma production by CD8(+) T cells was severely impaired. V gamma 4 subset was the major gamma delta T cell subset mediating the GVL effect in vivo, which was partially dependent on IL-17A. Meanwhile, donor gamma delta T cells could mitigate acute GVHD in a murine allo-HSCT model by suppressing CD4(+) T cell activation and the major gamma delta T cell subset that exerted this protective function was also V gamma 4 gamma delta T cells. Therefore, our findings provide evidence that donor gamma delta T cells, especially V gamma 4 subset, can enhance GVL effect and mitigate aGVHD during allo-HSCT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available